Neuropharmacology & Brain Health
Exploring the mechanisms of brain function and dysfunction to develop therapies for neurological and psychiatric disorders.
Research in this theme spans neurodegeneration, stroke, stress-related disorders, and the gut-brain axis, using cutting-edge models and translational approaches.
Researchers:
- Prof Aideen Sullivan (Parkinson’s disease, neurotrophic therapies)
- Dr Barry Boland (lysosomal flux in Alzheimer’s)
- Prof Christian Waeber (stroke, neuroprotection)
- Dr Rachel Moloney (PTSD, stress neurobiology)
- Dr Jatin Nagpal (microbiome and social behaviour in zebrafish)
- Dr Linda Katona (GABAergic circuits and schizophrenia)
- Dr Freiderike Uhlig (gut-brain signalling in GI disorders)